Home
Contact Us
Site Map

 

Rx to OTC Switches

“Edgewood provided incredibly valuable support for our recent OTC switch.”

“...approach to managing the category was considered innovative, truly objective and most importantly... a benchmark for other thought leaders in our industry.”
– Category manager - leading retailer

Products switching from pharmaceutical to over-the-counter status, such as Claritin® and Prilosec®, are a major industry phenomenon.

Edgewood Consulting has worked on several “switch” engagements with manufacturers and conducted benchmarking studies to identify Best Practice implementation principles.

Edgewood Consulting Group’s award-winning experience helps clients introduce or defend against Rx to OTC switches. We help manufacturers and their retail partners maximize ‘switch’ results in three critical areas:

  • Retail Commercialization/Entry Strategy
  • Competitive Defense
  • Rapid Implementation Technology



© 2010 Edgewood Consulting Group